AI Polyphenol Efficacy Assessment Using Wearables and Feedback
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The complex nature of nutraceutical polyphenols makes it difficult to assess their efficacy, often leading to premature discontinuation of supplements due to lack of noticeable effects, which can result in abandoning effective regimens for less effective options.
Innovation Solution
A system utilizing artificial intelligence (AI) and machine learning (ML) to collect and analyze user health data from wearable biosensors, surveys, and image inputs to assess the efficacy of polyphenol supplements, providing personalized dosage recommendations based on long-term health improvements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional methods are used to assess polyphenol efficacy, then the assessment process is simple, but the measurement precision is insufficient and leads to premature discontinuation
Solution Approach 1:
The assessment system is divided into multiple independent measurement modules, each targeting specific health parameters (oxidative stress markers, inflammation indicators, cellular health metrics). This segmentation allows precise measurement of different efficacy aspects without overwhelming complexity in a single system.
Solution Approach 2:
The patent introduces AI/ML algorithms as intermediary components that process and interpret complex health data from multiple sources. These algorithms act as mediators between raw measurement data and efficacy conclusions, enabling precise assessment while managing system complexity through automated analysis.
2Reliability
If comprehensive health tracking is implemented, then the reliability of efficacy assessment improves, but the loss of time increases due to extended monitoring periods
Solution Approach 1:
The system performs preliminary baseline assessments of health parameters before polyphenol supplementation begins. This establishes reference points that enable earlier detection of efficacy changes, reducing the time needed for comprehensive monitoring while maintaining high reliability through structured pre-establishment of measurement criteria.
Solution Approach 2:
The patent implements continuous feedback loops where health data is continuously monitored, analyzed by AI/ML algorithms, and used to provide real-time efficacy assessments. This feedback mechanism allows for dynamic adjustment of monitoring intensity and timing, maintaining reliability while optimizing time expenditure by focusing measurements on critical decision points.
3Adaptability or versatility
If multiple data collection sources are used, then the adaptability of the system improves, but the device complexity increases
Solution Approach 1:
The system employs a universal data collection framework that can integrate multiple diverse data sources (wearable devices, laboratory tests, dietary logs, genetic data) through a common processing architecture. This multi-functional approach enables the system to adapt to various data types while managing complexity through standardized integration protocols.
Solution Approach 2:
The patent dynamically adjusts data collection parameters and sources based on individual user needs, health status, and research objectives. The system can modify which sensors and measurement protocols are activated, allowing high adaptability to different assessment scenarios while managing complexity through conditional activation rather than maintaining all components simultaneously.
Data Source
AI summary
There is disclosed a system, method, and apparatus for assessing the efficacy of nutraceutical polyphenol supplements and dosage regimen utilizing artificial intelligence (AI). More particularly, in an embodiment, the present system, method and apparatus are configured to assess the efficacy of polyphenols derived from various different types of food sources. In an embodiment, user health data is collected from a plurality of sources including user wearable biosensors, user surveys input via mobile devices, optional user blood testing, and images of the user taken via the mobile devices.